Polar Capital Holdings Plc - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 97 filers reported holding Y-MABS THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Polar Capital Holdings Plc ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$22,118,480
-25.7%
1,831,0000.0%0.13%
-16.7%
Q1 2024$29,772,060
+112.2%
1,831,000
-11.0%
0.16%
+81.4%
Q4 2023$14,027,867
+22.4%
2,056,872
-2.2%
0.09%
+1.2%
Q3 2023$11,462,974
-19.7%
2,103,2980.0%0.08%
+18.1%
Q2 2023$14,281,393
+43.1%
2,103,298
+5.6%
0.07%
+10.8%
Q1 2023$9,979,564
+2.7%
1,991,9290.0%0.06%
-15.6%
Q4 2022$9,720,614
-73.4%
1,991,929
-21.3%
0.08%
-67.0%
Q3 2022$36,505,000
-18.3%
2,531,546
-14.3%
0.23%
-11.1%
Q2 2022$44,674,000
+30.7%
2,952,671
+2.6%
0.26%
+70.1%
Q1 2022$34,187,000
+53.1%
2,877,671
+108.9%
0.15%
+83.3%
Q4 2021$22,332,000
-32.3%
1,377,671
+19.3%
0.08%
-37.8%
Q3 2021$32,963,000
+66.4%
1,154,961
+97.1%
0.14%
+57.0%
Q2 2021$19,804,000
+8049.8%
585,921
+7197.6%
0.09%
+4200.0%
Q1 2021$243,000
-99.0%
8,029
-98.4%
0.00%
-98.7%
Q4 2020$25,133,000507,6330.15%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$2,757,0009.37%
Sofinnova Investments, Inc. 2,194,278$31,641,0001.84%
MPM BioImpact LLC 443,702$6,398,0001.52%
Artal Group S.A. 400,000$5,768,0000.25%
Polar Capital Holdings Plc 2,531,546$36,505,0000.23%
ASHFORD CAPITAL MANAGEMENT INC 101,970$1,470,0000.22%
Lombard Odier Asset Management (Switzerland) SA 168,795$2,434,0000.21%
Soleus Capital Management, L.P. 87,182$1,257,0000.17%
Cormorant Asset Management, LP 150,000$2,163,0000.15%
Walleye Capital LLC 437,344$6,307,0000.12%
View complete list of Y-MABS THERAPEUTICS INC shareholders